Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony P Conley

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Cancer|February 18, 2010
Cause of death in patients with lower-risk myelodysplastic syndromeFarshid Dayyani, Anthony P Conley, Sara S Strom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional ChondrosarcomaWilliam D Tap, Gregory M Cote, Howard Burris, et al.
Frontiers in Oncology|October 17, 2022
Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panelsFranco Rubino, Christopher Alvarez-Breckenridge, Kadir Akdemir, et al.
Clinical Sarcoma Research|June 21, 2017
Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypesJason Roszik, Wei-Lien Wang, John A Livingston, et al.
Cancers|May 14, 2025
TFCP2 Fusion-Positive Rhabdomyosarcomas: A Report of 10 Cases and a Review of the LiteratureMadison P Ginn, Ryan A Denu, Davis R Ingram, et al.
Clinical Sarcoma Research|August 13, 2020
Successful treatment of lipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusion inhibitorMegan Dupuis, Yulei Shen, Christian Curcio, et al.
Journal of Global Oncology|September 23, 2018
Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case ReportAnthony P Conley, Van Anh Trinh, Chrystia M Zobniw, et al.
The British Journal of Radiology|November 19, 2015
MRI may be used as a prognostic indicator in patients with extra-abdominal desmoid tumoursFirouzeh Kamali, Wei-Lien Wang, B A Guadagnolo, et al.
Molecular Cancer Therapeutics|March 5, 2020
Genomics, Morphoproteomics, and Treatment Patterns of Patients with Alveolar Soft Part Sarcoma and Response to Multiple Experimental TherapiesRoman Groisberg, Jason Roszik, Anthony P Conley, et al.
Frontiers in Oncology|March 2, 2026
Case Report: Complete response to the concurrent neoadjuvant radiation therapy and pembrolizumab in a locally recurrent, chemotherapy-refractory undifferentiated pleomorphic sarcoma of boneBrina A Patel, Jason T Smith, Sintawat Wangsiricharoen, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Cancer|February 18, 2010
Cause of death in patients with lower-risk myelodysplastic syndromeFarshid Dayyani, Anthony P Conley, Sara S Strom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional ChondrosarcomaWilliam D Tap, Gregory M Cote, Howard Burris, et al.
Frontiers in Oncology|October 17, 2022
Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panelsFranco Rubino, Christopher Alvarez-Breckenridge, Kadir Akdemir, et al.
Clinical Sarcoma Research|June 21, 2017
Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypesJason Roszik, Wei-Lien Wang, John A Livingston, et al.
Cancers|May 14, 2025
TFCP2 Fusion-Positive Rhabdomyosarcomas: A Report of 10 Cases and a Review of the LiteratureMadison P Ginn, Ryan A Denu, Davis R Ingram, et al.
Clinical Sarcoma Research|August 13, 2020
Successful treatment of lipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusion inhibitorMegan Dupuis, Yulei Shen, Christian Curcio, et al.
Journal of Global Oncology|September 23, 2018
Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case ReportAnthony P Conley, Van Anh Trinh, Chrystia M Zobniw, et al.
The British Journal of Radiology|November 19, 2015
MRI may be used as a prognostic indicator in patients with extra-abdominal desmoid tumoursFirouzeh Kamali, Wei-Lien Wang, B A Guadagnolo, et al.
Molecular Cancer Therapeutics|March 5, 2020
Genomics, Morphoproteomics, and Treatment Patterns of Patients with Alveolar Soft Part Sarcoma and Response to Multiple Experimental TherapiesRoman Groisberg, Jason Roszik, Anthony P Conley, et al.
Frontiers in Oncology|March 2, 2026
Case Report: Complete response to the concurrent neoadjuvant radiation therapy and pembrolizumab in a locally recurrent, chemotherapy-refractory undifferentiated pleomorphic sarcoma of boneBrina A Patel, Jason T Smith, Sintawat Wangsiricharoen, et al.
Pageof 8